5:39 PM
 | 
Jun 20, 2014
 |  BC Extra  |  Top Story

Shire rejects AbbVie bids

Shire plc (LSE:SHP; NASDAQ:SHPG) gained $31.18 (16%) to $222.89 on NASDAQ and was up 633p (17%) to 4,371p in London on Friday after disclosing its board rejected an unsolicited offer from AbbVie Inc. (NYSE:ABBV) to acquire Shire. The price valued Shire for about...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >